These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 25721870

  • 1. Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity.
    Wang Z, Zhang H, Dai L, Song T, Li P, Liu Y, Wang L.
    Cell Biochem Biophys; 2015 Sep; 73(1):213-9. PubMed ID: 25721870
    [Abstract] [Full Text] [Related]

  • 2. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W, Wang M, Wang L, Ji S, Zhang J, Zhang C.
    Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
    [Abstract] [Full Text] [Related]

  • 3. Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells.
    Morino Y, Sugiyama H, Yamane K, Kikuchi M, Yamanaka T, Honda K, Monzen S.
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38963046
    [Abstract] [Full Text] [Related]

  • 4. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS, Cheong HJ, Kim SJ, Kim KH, Lee N, Park HS, Won JH.
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [Abstract] [Full Text] [Related]

  • 5. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY, Lam SK, Li YY, Fong BM, Mak JC, Ho JC.
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [Abstract] [Full Text] [Related]

  • 6. Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts.
    Iriyama N, Yuan B, Yoshino Y, Hatta Y, Horikoshi A, Aizawa S, Takeuchi J, Toyoda H.
    Oncol Rep; 2013 Jun; 29(6):2362-8. PubMed ID: 23563754
    [Abstract] [Full Text] [Related]

  • 7. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y.
    Clin Cancer Res; 2012 Dec 15; 18(24):6690-701. PubMed ID: 23082001
    [Abstract] [Full Text] [Related]

  • 8. Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma.
    Yang L, Wang Y, Guo H, Guo M.
    Cell Biochem Biophys; 2015 Apr 15; 71(3):1379-85. PubMed ID: 25384619
    [Abstract] [Full Text] [Related]

  • 9. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W, Adachi M, Zhang R, Zhou J, Zhu D.
    Pancreas; 2009 May 15; 38(4):e114-23. PubMed ID: 19342982
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
    Iriyama N, Yuan B, Hatta Y, Horikoshi A, Yoshino Y, Toyoda H, Aizawa S, Takeuchi J.
    Oncol Rep; 2012 Nov 15; 28(5):1875-82. PubMed ID: 22940758
    [Abstract] [Full Text] [Related]

  • 11. Icariin induces apoptosis in acute promyelocytic leukemia by targeting PIM1.
    Zhang H, Li P, Li J, Song T, Wang L, Li E, Wang J, Wang L, Wei N, Wang Z.
    Pharmacol Rep; 2017 Dec 15; 69(6):1270-1281. PubMed ID: 29128809
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA, Silva dos Santos GA, Gimenes Teixeira HL, Scheucher PS, Lucena-Araujo AR, Lima AS, Abreu e Lima RS, Garcia AB, Jordão AA, Falcão RP, Vannucchi H, Rego EM.
    Leuk Res; 2009 Jul 15; 33(7):958-63. PubMed ID: 19013639
    [Abstract] [Full Text] [Related]

  • 13. Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.
    Zaki Dizaji M, Ghaffari SH, Hosseini E, Alizadeh N, Rostami S, Momeny M, Alimoghaddam K, Ghavamzadeh A.
    Asia Pac J Clin Oncol; 2017 Apr 15; 13(2):e21-e30. PubMed ID: 27770503
    [Abstract] [Full Text] [Related]

  • 14. BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.
    Bashash D, Ghaffari SH, Zaker F, Kazerani M, Hezave K, Hassani S, Rostami M, Alimoghaddam K, Ghavamzadeh A.
    Anticancer Agents Med Chem; 2013 Sep 15; 13(7):1115-25. PubMed ID: 23293885
    [Abstract] [Full Text] [Related]

  • 15. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
    Ramos AM, Aller P.
    Biochem Pharmacol; 2008 May 15; 75(10):1912-23. PubMed ID: 18359480
    [Abstract] [Full Text] [Related]

  • 16. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
    Qu H, Tong D, Zhang Y, Kang K, Zhang Y, Chen L, Ren L.
    Pharmazie; 2013 Oct 15; 68(10):839-45. PubMed ID: 24273890
    [Abstract] [Full Text] [Related]

  • 17. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    Chen G, Wang K, Yang BY, Tang B, Chen JX, Hua ZC.
    Int J Oncol; 2012 Jan 15; 40(1):139-47. PubMed ID: 21947421
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
    Dbaibo GS, Kfoury Y, Darwiche N, Panjarian S, Kozhaya L, Nasr R, Abdallah M, Hermine O, El-Sabban M, de Thé H, Bazarbachi A.
    Haematologica; 2007 Jun 15; 92(6):753-62. PubMed ID: 17550847
    [Abstract] [Full Text] [Related]

  • 19. cAMP protects acute promyelocytic leukemia cells from arsenic trioxide-induced caspase-3 activation and apoptosis.
    Safa M, Mousavizadeh K, Noori S, Pourfathollah A, Zand H.
    Eur J Pharmacol; 2014 Aug 05; 736():115-23. PubMed ID: 24815320
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R, Xia L, Gabrilove J, Waxman S, Jing Y.
    Leukemia; 2013 Feb 05; 27(2):315-24. PubMed ID: 22751450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.